Suppr超能文献

高糖增强L-FABP介导的贝特类药物对小鼠肝细胞中PPARα的诱导作用。

High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.

作者信息

Petrescu Anca D, McIntosh Avery L, Storey Stephen M, Huang Huan, Martin Gregory G, Landrock Danilo, Kier Ann B, Schroeder Friedhelm

机构信息

Department of Physiology and Pharmacology, Texas A&M University, TVMC, College Station, TX 77843-4466, USA.

出版信息

Biochim Biophys Acta. 2013 Aug;1831(8):1412-25. doi: 10.1016/j.bbalip.2013.05.008. Epub 2013 Jun 6.

Abstract

Although liver fatty acid binding protein (L-FABP) binds fibrates and PPARα in vitro and enhances fibrate induction of PPARα in transformed cells, the functional significance of these findings is unclear, especially in normal hepatocytes. Studies with cultured primary mouse hepatocytes show that: 1) At physiological (6mM) glucose, fibrates (bezafibrate, fenofibrate) only weakly activated PPARα transcription of genes in LCFA β-oxidation; 2) High (11-20mM) glucose, but not maltose (osmotic control), significantly potentiated fibrate-induction of mRNA of these and other PPARα target genes to increase LCFA β-oxidation. These effects were associated with fibrate-mediated redistribution of L-FABP into nuclei-an effect prolonged by high glucose-but not with increased de novo fatty acid synthesis from glucose; 3) Potentiation of bezafibrate action by high glucose required an intact L-FABP/PPARα signaling pathway as shown with L-FABP null, PPARα null, PPARα inhibitor-treated WT, or PPARα-specific fenofibrate-treated WT hepatocytes. High glucose alone in the absence of fibrate was ineffective. Thus, high glucose potentiation of PPARα occurred through FABP/PPARα rather than indirectly through other PPARs or glucose induced signaling pathways. These data indicated L-FABP's importance in fibrate-induction of hepatic PPARα LCFA β-oxidative genes, especially in the context of high glucose levels.

摘要

尽管肝脂肪酸结合蛋白(L-FABP)在体外能结合贝特类药物和过氧化物酶体增殖物激活受体α(PPARα),并增强贝特类药物对转化细胞中PPARα的诱导作用,但这些发现的功能意义尚不清楚,尤其是在正常肝细胞中。对原代培养小鼠肝细胞的研究表明:1)在生理浓度(6mM)葡萄糖条件下,贝特类药物(苯扎贝特、非诺贝特)仅微弱激活参与长链脂肪酸(LCFA)β-氧化的基因的PPARα转录;2)高浓度(11 - 20mM)葡萄糖而非麦芽糖(渗透压对照)能显著增强贝特类药物对这些以及其他PPARα靶基因mRNA的诱导作用,从而增加LCFAβ-氧化。这些效应与贝特类药物介导的L-FABP重新分布至细胞核有关——高葡萄糖可延长此效应——但与葡萄糖从头合成脂肪酸增加无关;3)高葡萄糖增强苯扎贝特作用需要完整的L-FABP/PPARα信号通路,这在L-FABP基因敲除、PPARα基因敲除、用PPARα抑制剂处理的野生型(WT)或用PPARα特异性非诺贝特处理的WT肝细胞中得到证实。在无贝特类药物时,单独的高葡萄糖无效。因此,PPARα的高葡萄糖增强作用是通过FABP/PPARα发生的,而非通过其他PPARs或葡萄糖诱导的信号通路间接发生。这些数据表明L-FABP在贝特类药物诱导肝脏PPARα LCFAβ-氧化基因方面具有重要性,尤其是在高葡萄糖水平的情况下。

相似文献

引用本文的文献

9
Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice.膳食叶绿醇对 SCP2/SCPX/L-FABP 基因敲除小鼠脂代谢的影响。
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Mar;1862(3):291-304. doi: 10.1016/j.bbalip.2016.12.002. Epub 2016 Dec 6.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验